tradingkey.logo

Vivos Therapeutics Inc

VVOS
查看详细走势图
1.970USD
-0.010-0.51%
收盘 12/19, 16:00美东报价延迟15分钟
16.29M总市值
亏损市盈率 TTM

Vivos Therapeutics Inc

1.970
-0.010-0.51%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-0.51%

5天

-4.83%

1月

-7.08%

6月

-29.64%

今年开始到现在

-54.08%

1年

-60.44%

查看详细走势图

TradingKey Vivos Therapeutics Inc股票评分

单位: USD 更新时间: 2025-12-19

操作建议

Vivos Therapeutics Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名127/208位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价5.50。中期看,股价处于下降通道。近一个月,市场表现较差,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Vivos Therapeutics Inc评分

相关信息

行业排名
127 / 208
全市场排名
296 / 4582
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 3 位分析师
买入
评级
5.500
目标均价
+154.63%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Vivos Therapeutics Inc亮点

亮点风险
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
业绩增长期
公司处于发展阶段,最新年度总收入15.03M美元
估值合理
公司最新PE估值-1.11,处于3年历史合理位
机构减仓
最新机构持股815.76K股,环比减少2.60%
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值91.46K

Vivos Therapeutics Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Vivos Therapeutics Inc简介

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
公司代码VVOS
公司Vivos Therapeutics Inc
CEOHuntsman (R. Kirk)
网址https://vivos.com/

常见问题

Vivos Therapeutics Inc(VVOS)的当前股价是多少?

Vivos Therapeutics Inc(VVOS)的当前股价是 1.970。

Vivos Therapeutics Inc的股票代码是什么?

Vivos Therapeutics Inc的股票代码是VVOS。

Vivos Therapeutics Inc股票的52周最高点是多少?

Vivos Therapeutics Inc股票的52周最高点是7.950。

Vivos Therapeutics Inc股票的52周最低点是多少?

Vivos Therapeutics Inc股票的52周最低点是1.925。

Vivos Therapeutics Inc的市值是多少?

Vivos Therapeutics Inc的市值是16.29M。

Vivos Therapeutics Inc的净利润是多少?

Vivos Therapeutics Inc的净利润为-11.14M。

现在Vivos Therapeutics Inc(VVOS)的股票是买入、持有还是卖出?

根据分析师评级,Vivos Therapeutics Inc(VVOS)的总体评级为买入,目标价格为5.500。

Vivos Therapeutics Inc(VVOS)股票的每股收益(EPS TTM)是多少

Vivos Therapeutics Inc(VVOS)股票的每股收益(EPS TTM)是-1.772。
KeyAI